AEMD stock icon

Aethlon Medical
AEMD

$0.69
20.74%
 

About: Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Employees: 15

0
Funds holding %
of 6,689 funds
Analysts bullish %
0
News positive %
of 5 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.11% less ownership

Funds ownership: 2.09% [Q4 2023] → 1.98% (-0.11%) [Q1 2024]

17% less funds holding

Funds holding: 12 [Q4 2023] → 10 (-2) [Q1 2024]

23% less capital invested

Capital invested by funds: $114K [Q4 2023] → $87.3K (-$26.4K) [Q1 2024]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$10
1,356%
upside
Avg. target
$10
1,356%
upside
High target
$10
1,356%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Vernon Bernardino
1,356%upside
$10
Buy
Maintained
4 Mar 2024

Financial journalist opinion

Based on 5 articles about AEMD published over the past 30 days